Association of baseline characteristics with clinical outcomes of tirzepatide treatment in Japanese patients with obesity disease: A subgroup analysis of the <scp>SURMOUNT</scp> ‐J trial

Authors

Institutions

Publication Details

Journal
Diabetes Obesity and Metabolism
Published
2025-11-25
DOI
https://doi.org/10.1111/dom.70315
Primary Topic
Menopause: Health Impacts and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of baseline characteristics with clinical outcomes of tirzepatide treatment in Japanese patients with obesity disease: A subgroup analysis of the SURMOUNT ‐J trial

Yasushi Fukushima, Wataru Ogawa, Tomotaka Shingaki, Tomonori Oura et al.
Diabetes Obesity and Metabolism
Menopause: Health Impacts and Treatments
article

Association of baseline characteristics with clinical outcomes of tirzepatide treatment in Japanese patients with obesity disease: A subgroup analysis of the SURMOUNT ‐J trial

Yasushi Fukushima, Wataru Ogawa, Tomotaka Shingaki, Tomonori Oura, Koutaro Yokote
article en

Abstract

No abstract available for this paper.
Diabetes Obesity and MetabolismVol. 28(2)
Chiba University (JP), Eli Lilly (Japan) (JP), Kobe University (JP)
Eli Lilly and Company, Mitsubishi Tanabe Pharma Corporation, Eli Lilly Japan
Openalex Percentile: Top 52%
Menopause: Health Impacts and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.